Rheumnow Podcast

A New RA Approval (8.1.2025)

Dr. Jack Cush reviews the news, journal reports and a new treatment for RA from the FDA.

CKD & Osteoporosis Rx Revisited (7.25.2025)

Dr. Jack Cush reviews the news, journal and FDA updates from this past week on RheumNow.com

NHANES, Numbers, & Risk (7.18.2025)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Interesting case questions from "Ask Cush Anything"

Hmmm Really? (7.11.2025)

Dr. Jack Cush reviews the news and journal reports from this past week - some obvious, other new thoughts and some - hmmm, reallly?

 

PCR- Prevalence, Cost, & Risk (6.27.2025)

Dr. Jack Cush reviews the news and journal reports from last week on RheumNow.com

EULAR 2025 Rheumatology RoundUp Hosted by Dr. John J. Cush and Dr. Arthur Kavanaugh

Join rheumatology experts Dr. John J. Cush and Dr. Arthur Kavanaugh for the EULAR Rheumatology RoundUp — a dynamic, fast-paced discussion capturing the most impactful highlights, late-breaking data, and clinical takeaways from EULAR 2025.

EULAR 2025 - Day 9 podcast

Trends and Innovations from Barcelona (6.20.2025)
AI Advances axSpA Diagnosis with Multimodal MRI
IL-17 Inhibitors in Psoriatic Arthritis
IL-17 Inhibitors for Axial Spondyloarthritis
New IL-17 Inhibition New Molecular Constructs

Trends and Innovations from Barcelona (6.20.2025)

EULAR 2025 - Day 8 podcast

Resilience or Resignation? Rethinking Pain, Aging, and Quality of Life
Spondyloarthritis Panel: Eular 2025

EULAR 2025 – SpA Panel Discussion

Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.